Literature DB >> 29160515

Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study.

João Victor Soares Coriolano Coutinho1, Fabiana Silva Dos Santos1, Rosângela do Socorro Pereira Ribeiro1, Iara Brito Bucar Oliveira1, Victória Bezerra Dantas1, Ana Barbara Feliciano Souza Santos1, Jéssyca Rodrigues Tauhata1.   

Abstract

INTRODUCTION: This study aimed to draw clinical and epidemiological comparisons between visceral leishmaniasis (VL) and VL associated with human immunodeficiency virus (HIV) infection.
METHOD: Retrospective study.
RESULTS: Of 473 cases of VL, 5.5% were coinfected with HIV. The highest proportion of cases of both VL and VL/HIV were found among men. A higher proportion of VL cases was seen in children aged 0-10 years, whereas coinfection was more common in those aged 18-50 years.
CONCLUSIONS: VL/HIV coinfected patients presented slightly differently to and had a higher mortality rate than those with VL only.

Entities:  

Mesh:

Year:  2017        PMID: 29160515     DOI: 10.1590/0037-8682-0193-2017

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  7 in total

1.  Magnitude of visceral leishmaniasis and HIV coinfection and association with social determinants of health in the Northeast region of Brazil: a retrospective, spatiotemporal model (2010-2018).

Authors:  Erica Santos Dos Reis; Caíque Jordan Nunes Ribeiro; Allan Dantas Dos Santos; Damião da Conceição Araújo; Márcio Bezerra-Santos; Eliete Rodrigues da Silva; Rogério Silva Santos; Wandklebson Silva Paz; Rosália Elen Santos Ramos; Priscila Lima Dos Santos; Michael Wheeler Lipscomb; Karina Conceição Gomes M de Araújo; Tatiana Rodrigues de Moura
Journal:  Parasitol Res       Date:  2022-02-10       Impact factor: 2.289

2.  Visceral leishmaniasis in a Brazilian endemic area: an overview of occurrence, HIV coinfection and lethality.

Authors:  João Gabriel Guimarães Luz; Danilo Bueno Naves; Amanda Gabriela de Carvalho; Gilvani Alves Meira; João Victor Leite Dias; Cor Jesus Fernandes Fontes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-03-08       Impact factor: 1.846

Review 3.  Visceral leishmaniasis and HIV coinfection: current perspectives.

Authors:  José Angelo Lauletta Lindoso; Carlos Henrique Valente Moreira; Mirella Alves Cunha; Igor Thiago Queiroz
Journal:  HIV AIDS (Auckl)       Date:  2018-10-15

4.  Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.

Authors:  Farhat Afrin; Garima Chouhan; Mohammad Islamuddin; Muzamil Y Want; Hani A Ozbak; Hassan A Hemeg
Journal:  PLoS Negl Trop Dis       Date:  2019-05-09

Review 5.  Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity.

Authors:  John M Curtin; Naomi E Aronson
Journal:  Microorganisms       Date:  2021-03-11

6.  ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.

Authors:  Nathalia C Galvani; Amanda S Machado; Daniela P Lage; Camila S Freitas; Danniele L Vale; Daysiane de Oliveira; Fernanda Ludolf; Fernanda F Ramos; Bruna B Fernandes; Gabriel P Luiz; Débora V C Mendonça; João A Oliveira-da-Silva; Thiago A R Reis; Grasiele S V Tavares; Ana T Chaves; Nathalia S Guimarães; Unaí Tupinambás; Gláucia F Cota; Maria V Humbert; Vívian T Martins; Myron Christodoulides; Eduardo A F Coelho; Ricardo A Machado-de-Ávila
Journal:  Parasitol Res       Date:  2021-10-19       Impact factor: 2.289

7.  Thymoquinone Induced Leishmanicidal Effect via Programmed Cell Death in Leishmania donovani.

Authors:  Mohammad Islamuddin; Abuzer Ali; Obaid Afzal; Amena Ali; Intzar Ali; Abdulmalik Saleh Alfawaz Altamimi; Mubarak A Alamri; Kentaro Kato; Shama Parveen
Journal:  ACS Omega       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.